Transcription of Syringe Services Programs Technical Package
{{id}} {{{paragraph}}}
Syringe Services Programs A Technical Package of Effective Strategies and Approaches for Planning, Design, and ImplementationDEVELOPED BYZulqarnain Javed, PhD, MPH1 Katie Burk, MPH2 Shelley Facente, PhDc, MPH2 Laura Pegram, MPH, MSW2 Aliyah Ali, MPH3 Alice Asher, RN, PhD31 Satcher Health Leadership Institute, Morehouse School of Medicine, Atlanta, Georgia2 NASTAD, Washington, District of Columbia3 National Center for HIV/AIDS, Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA2020 Acknowledgments This document was developed by the National Alliance of State and Territorial AIDS Directors (NASTAD), under funding announcement CDC-RFA-OT18-1802 for, and in collaboration with, the Centers for Disease Control a
people at high risk for HIV infection, to prevent them from acquiring HIV when exposed. This currently requires a daily oral pill, but other treatments are in development and testing, including a long-acting injectable medication. Retractable syringes — syringes that are designed to be single-use only, primarily created to reduce the chance
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}